{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:07:08Z","timestamp":1767179228591,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pntd.0008028","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000}}],"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008028","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T13:35:44Z","timestamp":1580132144000},"page":"e0008028","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-2676","authenticated-orcid":true,"given":"Andrea","family":"Kuemmerle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caecilia","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Kande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Mutombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medard","family":"Ilunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Lumpungu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Mutanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pathou","family":"Nganzobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Digas","family":"Ngolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mays","family":"Kisala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Valverde Mordt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"pntd.0008028.ref001","first-page":"1","author":"WHO","year":"2013"},{"issue":"11","key":"pntd.0008028.ref002","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1086\/429929","article-title":"Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: Confirmation from a multinational study (Impamel II)","volume":"191","author":"C Schmid","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"pntd.0008028.ref003","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.trstmh.2008.09.005","article-title":"Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Medecins Sans Frontieres programmes","volume":"103","author":"M Balasegaram","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"pntd.0008028.ref004","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3201\/eid1106.050036","article-title":"Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982\u20132001","volume":"11","author":"J Pepin","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"pntd.0008028.ref005","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1406.071266","article-title":"High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo","volume":"14","author":"J Robays","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"Supp 1","key":"pntd.0008028.ref006","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00436-002-0766-5","article-title":"Eflornithine for the treatment of human African trypanosomiasis","volume":"90","author":"C Burri","year":"2003","journal-title":"Parasitol Res"},{"key":"pntd.0008028.ref007","unstructured":"WHO. World Health Organization Model List of Essential Medicines, 16th list. 2010."},{"key":"pntd.0008028.ref008","unstructured":"WHO. World Health Organization Model List of Essential Medicines for children, 19th list. 2012."},{"key":"pntd.0008028.ref009","article-title":"Fexinidazole: First Global Approval","author":"ED Deeks","year":"2019","journal-title":"Drugs"},{"issue":"10116","key":"pntd.0008028.ref010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","article-title":"Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial","volume":"391","author":"V Mesu","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"pntd.0008028.ref011","doi-asserted-by":"crossref","first-page":"e0007381","DOI":"10.1371\/journal.pntd.0007381","article-title":"The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis","volume":"13","author":"E Pelfrene","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008028.ref012","unstructured":"WHO. Interim guidelines for the treatment of gambiense human African trypanosomiasis. 2019."},{"issue":"11","key":"pntd.0008028.ref013","doi-asserted-by":"crossref","first-page":"e1920","DOI":"10.1371\/journal.pntd.0001920","article-title":"In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness","volume":"6","author":"C Schmid","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008028.ref014","unstructured":"< Program CTE. Common Terminology Criteria for Adverse Events, Version 3.0 2006 [20.02.2012]. Available from: http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf."},{"issue":"1","key":"pntd.0008028.ref015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2005.08.001","article-title":"Clinical aspects of 2541 patients with second stage human African trypanosomiasis","volume":"97","author":"J Blum","year":"2006","journal-title":"Acta Trop"},{"issue":"9683","key":"pntd.0008028.ref016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"G Priotto","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"pntd.0008028.ref017","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.pntd.0000064","article-title":"Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series","volume":"1","author":"F Checchi","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"pntd.0008028.ref018","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pctr.0010039","article-title":"Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda","volume":"1","author":"G Priotto","year":"2006","journal-title":"PLoS Clin Trials"},{"issue":"2","key":"pntd.0008028.ref019","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cid\/cis886","article-title":"Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Medecins Sans Frontieres experience in the Democratic Republic of the Congo","volume":"56","author":"E Alirol","year":"2013","journal-title":"Clin Infect Dis"},{"key":"pntd.0008028.ref020","unstructured":"WHO. World Health Organization Model List of Essential Medicines, 21st list. 2019."}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0008028","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T13:49:23Z","timestamp":1580996963000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008028"}},"subtitle":[],"editor":[{"given":"Albert","family":"Picado","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008028","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]}}}